Oscillatory potentials and the b-Wave: Partial masking and interdependence in dark adaptation and diabetes in the rat

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 9, 2007, Pages 1335-1345

  Layton, Chris J ^a   Safa, R ^a   Osborne, N N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Dark adaptation; Diabetes; Electroretinogram

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B WAVE; CONTROLLED STUDY; CORRELATION ANALYSIS; DARK ADAPTATION; DIABETES MELLITUS; DISEASE DURATION; ELECTRORETINOGRAPHY; LATENT PERIOD; NONHUMAN; OSCILLATORY POTENTIAL; PRIORITY JOURNAL; RAT; SIGNAL DETECTION; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; DARK ADAPTATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; MALE; OSCILLOMETRY; PERCEPTUAL MASKING; RATS; RATS, WISTAR; RETINA; TIME FACTORS;

EID: 34548036046     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0506-0     Document Type: Article

References (45)

1. Aizu Y, Oyanagi K, Hu J, Nakagawa H (2002) Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats. Neuropathology 22:161-170
2. Amemiya T (1977) Dark adaptation in diabetics. Ophthalmologica 174:322-326
3. Arden GB, Wolf JE, Tsang Y (1998) Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis. Vis Res 38:1723-1729
4. Asi H, Perlman I (1992) Relationships between the electroretinogram a-wave, b-wave and oscillatory potentials and their application to clinical diagnosis. Doc Ophthalmol 79:125-139
5. Benoit J, Lachapelle P (1990) Temporal relationship between ERG components and geniculate unit activity in rabbit. Vis Res 30:797-806
6. Biro K, Palhalmi J, Toth AJ, Kukorelli T, Juhasz G (1998) Bimoclomol improves early electrophysiological signs of retinopathy in diabetic rats. Neuroreport 9:2029-2033
7. Brooks DE, Sims MH, Gum GG, Blackstock MJ (1992) Changes in oscillatory potentials of the canine electroretinogram during acute sequential elevations in intraocular pressure. Prog Vet Comp Ophthalmol 2:80-89
8. Brunette JR, Lafond G (1983) Effects of dark adaptation on implicit time in the clinical electroretinogram. Can J Ophthalmol 18:33-36
9. Bui BV, Armitage JA, Tolcos M, Cooper ME, Vingrys AJ (2003) ACE inhibition salvages the visual loss caused by diabetes. Diabetologia 46:401-408
10. Dick E, Miller RF (1978) Light-evoked potassium activity in mudpuppy retina: Its relationship to the b-wave of the electroretinogram. Brain Res 154:388-394
11. Feghali JG, Jin JC, Odom JV (1991) Effect of short-term intraocular pressure elevation on the rabbit electroretinogram. Invest Ophthalmol Vis Sci 32:2184-2189
12. Granit R (1933) Components of the retinal action potentials in mammals and their relation to the discharge in the optic nerve. J Physiol 77:207-239
13. Hancock HA, Kraft TW (2004) Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 45:1002-1008
14. Henson DB, North RV (1979) Dark adaptation in diabetes mellitus. Br J Ophthalmol 63:539-541
15. Hotta N, Koh N, Sakakibara F, Nakamura J, Hara T, Hamada Y, Fukasawa H, Kakuta H, Sakamoto N (1997) Effect of an aldose reductase inhibitor on abnormalities of electroretinogram and vascular factors in diabetic rats. Eur J Pharmacol 326:45-51
16. Hotta N, Koh N, Sakakibara F, Nakamura J, Hamara Y, Hara T, Nakashima E, Sasaki H, Fukasawa H, Kakuta H, Sakamoto N (1996) Effects of propionyl-L-carnitine and insulin on the electroretinogram, nerve conduction and nerve blood flow in rats with streptozotocin-induced diabetes. Pflugers Arch 431:564-570
17. Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Hara T, Mori K, Nakashima E, Naruse K, Fukasawa H, Kakuta H, Sakamoto N (1996) Effects of beraprost sodium and insulin on the electroretinogram, nerve conduction, and nerve blood flow in rats with streptozotocin-induced diabetes. Diabetes 45:361-366
18. Keller C, Grimm C, Wenzel A, Hafezi F, Reme C (2001) Protective effect of halothane anesthesia on retinal light damage: Inhibition of metabolic rhodopsin regeneration. Invest Ophthalmol Vis Sci 42:476-480
19. Lachapelle P (1987) Analysis of the photopic electroretinogram recorded before and after dark adaptation. Can J Ophthalmol 22:354-361
20. Lachapelle P (1990) Oscillatory potentials as predictors to amplitude and peak time of the photopic b-wave of the human electroretinogram. Doc Ophthalmol 75:73-82
21. Lachapelle P (1991) Evidence for an intensity-coding oscillatory potential in the human electroretinogram. Vis Res 31:767-774
22. Marmor MF, Zrenner E (1998) Standard for clinical electroretinography (1999 update). International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol 97:143-156
23. Marmor MF, Holder GE, Seeliger MW, Yamamoto S (2004) Standard for clinical electroretinography (2004 update). Doc Ophthalmol 108:107-114
24. Miller RF, Dowling JE (1970) Intracellular responses of the Muller (glial) cells of mudpuppy retina: Their relation to b-wave of the electroretinogram. J Neurophysiol 33:323-341
25. Miyake Y, Solish A, Hara A, Hirose T (1978) Clinical application of a digital computer software system to electrodiagnosis. Ophthalmic Res 10:268-278
26. Noell WK, Delmelle MC, Albrecht R (1971) Vitamin A deficiency effect on retina: Dependence on light. Science 172:72-75
27. Ogden TE (1973) The oscillatory waves of the primate electroretinogram. Vis Res 13:1059-1074
28. Ostroy SE (1998) Altered rhodopsin regeneration in diabetic mice caused by acid conditions within the rod photoreceptors. Curr Eye Res 17:979-985
29. Ostroy SE, Frede SM, Wagner EF, Gaitatzes CG, Janle EM (1994) Decreased rhodopsin regeneration in diabetic mouse eyes. Invest Ophthalmol Vis Sci 35:3905-3909
30. Perlman I (1983) Relationship between the amplitudes of the b-wave and the a wave as a useful index for evaluating the electroretinogram. Br J Ophthalmol 67:443-448
31. Rapp LM, Basinger SF (1982) The effects of local anaesthetics on retinal function. Vis Res 22:1097-1103
32. Sakai H, Tani Y, Shirasawa E, Shirao Y, Kawasaki K (1995) Development of electroretinographic alterations in streptozotocin-induced diabetes in rats. Ophthalmic Res 27:57-63
33. Seki M, Tanaka T, Nawa H, Usui T, Fukuchi T, Ikeda K, Abe H, Takei N (2004) Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: Therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 53:2412-2419
34. Sims MH (1990) Partial masking of the canine electroretinogram by oscillatory potentials: The problem of frequency bandwidth. J Vet Intern Med 4:40-42
35. Sims MH, Brooks DE (1990) Changes in oscillatory potentials of the canine electroretinogram during dark adaptation. Am J Vet Res 51:1580-1586
36. Stodmeister R (1973) The spectral sensitivity functions of human ERG wavelets. Ophthalmic Res 5:21-30
37. Strackee J, Van Der Tweel L (1974) Data analysis of electrophysiological signals. Doc Ophthalmol, Proc Ser 10:23-35
38. Tuitoek PJ, Ziari S, Tsin AT, Rajotte RV, Suh M, Basu TK (1996) Streptozotocin-induced diabetes in rats is associated with impaired metabolic availability of vitamin A (retinol). Br J Nutr 75:615-622
39. Tzekov R, Arden GB (1999) The electroretinogram in diabetic retinopathy. Surv Ophthalmol 44:53-60
40. Vadala M, Anastasi M, Lodato G, Cillino S (2002) Electroretinographic oscillatory potentials in insulin-dependent diabetes patients: A long-term follow-up. Acta Ophthalmol Scand 80:305-309
41. Van Der Torren K, Groeneweg G, Van Lith G (1988) Measuring oscillatory potential during the course of an arterial occlusion: A method based on Fourier analysis. Doc Ophthalmol 70:199-203
42. Wachtmeister L (1998) Oscillatory potentials in the retina: What do they reveal. Prog Retin Eye Res 17:485-521
43. Wachtmeister L, Dowling JE (1978) The oscillatory potentials of the mudpuppy retina. Invest Ophthalmol Vis Sci 17:1176-1188
44. Xu X, Karwoski CJ (1994) Current source density (CSD) analysis of retinal field potentials. I. Methodological considerations and depth profiles. J Neurophysiol 72:84-95
45. Xu X, Karwoski CJ (1994) Current source density analysis of retinal field potentials. II. Pharmacological analysis of the b-wave and M-wave. J Neurophysiol 72:96-105